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Edited by Gunnar von Heijne and Anders LiljasAbstract The molecular features of telomeres and telomerase
are conserved among most eukaryotes. How telomerase and telo-
meres function and how they interact to promote the chromo-
some-stabilizing properties of telomeres are discussed here.
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Telomeres, the DNA-protein complexes at the ends of
eukaryotic chromosomes, are protective against genome insta-
bility-promoting events. Such events can include degradation
of the terminal regions of chromosomes, fusion of a telomere,
either with another telomere or with a broken DNA end, or
inappropriate recombination. These processes are potentially
catastrophic; for example, fusions can lead to the formation
of dicentric chromosomes, which are inherently unstable and
result in imbalances in the genetic content of dividing cells
progeny, or to loss of genetic information. Telomeric DNA
consists of tandemly repeated, simple, often G-rich, sequences
speciﬁed by the action of telomerase. The tandem repeats form
a molecular scaﬀold containing many binding sites for telo-
meric proteins, which in turn nucleate the coalescence of a
higher order, although still ill-deﬁned, complex of protective
telomeric proteins, including the telomeric DNA-sequence-spe-
ciﬁc binding proteins. The resulting DNA-protein complex at
the telomere is dynamic; during interphase, the telomere-
bound proteins are exchanged on and oﬀ individual telomeres
at rates of the order of minutes or less, depending on which
protein components are examined [1].2. Telomerase: polymerizing enzyme and protector
The complete replication of telomeric DNA requires telome-
rase, a specialized cellular ribonucleoprotein RNP reverse
transcriptase (RT). The core enzyme contains the protein
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TER. By copying a short template sequence within its intrinsic
RNA moiety, telomerase synthesizes the telomeric DNA
strand running 5 0 to 3 0 toward the distal end of the chromo-
some, thereby extending it. Regulated extension of the chro-
mosomal DNA termini occurs to compensate for shortening
that results from nuclease action and incomplete terminal
DNA replication. A multi-component ‘‘telomere homeostasis’’
system prevents, on the one hand, the over-extension of telo-
meres. Protein–protein interactions among the telomere-asso-
ciated proteins are important for this function, which acts in
cis on a telomere [2].
Conversely, the telomeric homeostasis system acts to pro-
mote telomeric extension whenever a telomere becomes short-
ened, thereby keeping the tract of telomeric repeats within a
well-deﬁned range in telomerase-containing cells.
Telomerase functions in its capacity as a cellular RT using a
mechanism that results in the synthesis of the short, repeated
DNA sequence found at telomeres. Only a short region of
the telomerase RNA, the templating domain, is copied. The
telomerase RNA is bound at high aﬃnity by conserved do-
mains of TERT that lie outside its RT homology domain
([3]; and references therein). These and other RNA-protein
interactions between TERT and TER are critical to telomerase
function. In various species, telomerase is dimeric and within
the dimeric complex, its RNAs interact with each other in a
fashion that, under at least some experimental conditions,
can be crucially important for enzyme activity [4–6].
TER has a secondary core structure which is conserved
among eukaryotes in general. The core contains motifs that
not only bind TERT but also include sequences and elements
demonstrated to be critical for enzyme function, as reviewed
elsewhere [3] (see Fig. 1).
One example of the importance of the RNA structure is seen
in experiments changing a structural element in the RNA
(whose nature varies from species to species) that acts as a bar-
rier to synthesis beyond the template. RNA mutations in this
element can cause read-through synthesis, in which portions
of the telomerase RNA beyond the normal template boundary
are copied, both in vitro and in vivo. TERT binds to this ele-
ment; such binding, occurring as it does to a region of the
RNA close to the template, may depend on how this barrier
function is accomplished. However, various other mutations
in the structural and sequence elements of the telomerase
RNA core cause eﬀects that have been less easy to reconcile
with a mechanism solely involving TERT–TER binding. Someblished by Elsevier B.V. All rights reserved.
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activity. For example, speciﬁc point mutations in the templat-
ing domain can abolish enzymatic activity [7]. Certain base
changes in the template, in a fashion that currently appears idi-
osyncratic, cause incorrect usage of the RNA template, such as
DNA base misincorporation and mispair extension, or high
rates of slippage synthesis. This has been observed in Tetrahy-
mena, Kluyveromyces lactis and Saccharomyces cerevisiae telo-
merases. These errors lead to the synthesis of telomeric DNA
bearing signiﬁcant amounts of unpredicted DNA sequences
(reviewed in [8]).
In the telomerase of the budding yeast K. lactis, some muta-
tions in the conserved pseudoknot diminish or even ablate tel-
omerase enzymatic activity; other pseudoknot mutations cause
incomplete copying of the template sequence, such that only a
truncated region of the template is used and consequently mu-
tated (truncated) repeats are present at telomeres, causing cell
growth defects [9]. Hence, telomerase RNA bases play impor-
tant roles in enzyme function. The ultimate ability of telome-
rase to synthesize the correct telomeric DNA sequence is
needed not only to counteract telomere terminal attrition,
but also to synthesize the correct telomeric DNA binding sites
for the sequence-speciﬁc protective telomeric proteins.
Telomerase also acts to prevent chromosome fusions. The
net elongation of the bulk of the telomeres in a cell by telome-
rase can be uncoupled from its ability to protect from chromo-
some fusions, in yeast and human cells [10–13] (see Fig. 1).
Telomerase in yeast cells can be cross-linked to telomeric
DNA even during times in the cell cycle when it is not compe-
tent to polymerize DNA onto chromosome ends [14–16].Fig. 1. A universally conserved coreTogether, these results raise the possibility that telomerase
physically helps cap the chromosomal termini and thereby
may help protect telomeres against fusions.
Although it was not initially detected in cells that undergo
senescence in culture, telomerase activity can be found even
in these cells. This has been observed with such cells after they
have been passaged in culture or when they are fresh, and be-
fore they have been passaged. Telomerase activity was re-
ported to be readily detectable in primary chicken ﬁbroblasts
and in primary human endothelial cells soon after removal
from the bird/human, but to become greatly diminished after
culturing in vitro has got underway [17,18].
Cultured human ﬁbroblasts eventually undergo senescence,
before which their telomeres gradually shorten, and as the cells
enter senescence in culture, DNA damage foci accumulate spe-
ciﬁcally at telomeres [19]. Thus, the low amount of telomerase
in these cells is insuﬃcient to prevent their eventual telomere
uncapping or cellular senescence. Supplementing the meager
amounts of telomerase in primary cultured human cells, by
forced overexpression of TERT, can keep the cells multiplying
in culture. Even a hypomorphic telomerase allele that does not
cause net telomere shortening is able to prolong cell life span in
culture [10]. Conversely, eﬀectively swamping out the small
amount of endogenous functional telomerase, via overexpres-
sion of a catalytically dead point mutant of TERT protein,
causes premature senescence and apoptosis of primary human
ﬁbroblasts or keratinocytes ([10], and Fig. 2). Apoptosis simi-
larly increases upon overexpression of a catalytically compe-
tent but biologically non-functional point mutant of
telomerase ([10], and Fig. 2). These results suggest that, despitein telomerase RNA (from [3]).
Fig. 2. Apoptosis in normal human epithelial keratinocytes. At day 90
after beginning passaging cells in culture, FACS analysis was
performed. Top panels, forward and side scatter of ungated cells;
bottom panels, gated whole cells, y-axis, propidium iodine uptake (as a
measure of fraction of inviable cells) and x-axis, Annexin V staining (as
a measure of apoptosis) of cells transformed stably with hTERT
overexpression vectors carrying diﬀerent forms of human TERT as
described in Kim et al. [10]: WT, wild-type, +C, hTERT construct
bearing a 10-amino-acid C-terminal extension; NT, N125A, T126A
double point mutant of hTERT; DN, D868A catalytically dead
hTERT. Note that hTERT-WT or hTERT +C, both of which are
enzymatically active, decrease cell death, while NT-hTERT and
especially DN-hTERT dramatically increase cell death.
E.H. Blackburn / FEBS Letters 579 (2005) 859–862 861the eventual telomere shortening, uncapping and senescence
that ensues, even the low amount of telomerase in these cells
is partially protective. Together, these ﬁndings raise the possi-
bility that normal cells may never be truly telomerase-negative
in vivo, but, rather, have low amounts of telomerase that serve
some telomere-protective function.3. The hitherto-secret other life of the telomerase TERT subunit
TERT, the catalytic protein subunit of telomerase, is a large
(>100 kD) protein containing conserved domains outside itsFig. 3. Model for sequestration of TERT protein of telRT domain. An inhibitor of telomerase activity, the human
protein PinX1, was ﬁrst identiﬁed in mammalian cells by Lu
and colleagues and was shown to inhibit telomerase in vitro
and to bind TERT protein in vitro [20].
Extending the analysis of PinX1 to yeast led to the surprising
ﬁnding that in vivo, TERT can form an alternative, enzymat-
ically inactive complex lacking telomerase RNA. This TERT-
containing complex contains, instead, PinX1, which replaces
the telomerase RNA by binding to a domain of TERT protein
that overlaps with the RNA-binding domain. This TERT-
PinX1 complex is unable to synthesize telomeric DNA, since
it lacks the telomerase RNA. In yeast, it was found that PinX1
and the telomerase RNA bind to the same domain of TERT.
Furthermore, evidence that telomerase RNA and PinX1 both
compete for TERT binding in vivo was found [21].
Because PinX1 is a nucleolar protein in yeast, binding TERT
to PinX1 is expected to have the eﬀect of sequestering TERT in
the nucleolus, away from the telomeric DNA substrate of
enzymatic telomerase. Normal human cells have TERT dis-
tributed in the nucleolus and nucleoplasm, but in human can-
cer cells TERT primarily locates in the nucleoplasm, and it is
generally not detected in the nucleolus [22]. Evidence that
PinX1 is a tumor suppressor has been reported [20] and it is
often found to be diminished in amount in human cancers.
Hence, we have proposed that the mechanism by which PinX1
acts as a tumor suppressor is to sequester telomerase in the
nucleolus, and that loss of this regulatory mechanism pro-
motes tumorigenesis by freeing the available TERT to the
nucleoplasm, where it can carry out telomere maintenance
functions (see Fig. 3).
The ﬁnding that the large TERT protein, with its extensively
conserved domains outside its RT domain, can form a complex
diﬀerent from the enzymatically functional RNP opens up the
possibility that even more complexes of TERT, or of TER,
may exist in cells.omerase by the tumor suppressor protein PinX1.
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Mutations of the telomerase RNA template can cause corre-
spondingly mutated telomeric DNA sequences to be added to
telomeres in vivo. The responses of cells to such mutations do
not resemble the responses elicited by DNA damage, such as
double-stranded DNA breaks. In S. cerevisiae, such mutant
telomeres result in a pre-anaphase cell arrest phenotype in
which chromosomes do not separate, or show delayed separa-
tion. DNA damage foci containing Ddc1 or Ddc2 increase in
frequency in such cells over background. Whether these foci
reﬂect chromosome fusions and ensue breakage of the result-
ing dicentric chromosomes, or whether the foci are formed at
the aberrant telomeres themselves, was not distinguished.
However, the genetic dependencies for this mutant telomerase
template-induced arrest diﬀer from that of a conventional
DNA damage response; unlike a DNA damage response, the
arrest was not ameliorated by the absence of Mec1, Mec3,
Ddc1, Ddc2 or Mad1 [23]. Only when both the DNA damage
checkpoint and spindle checkpoint pathways were simulta-
neously disrupted did the cells fail to elicit the arrest response
to mutant-template telomerase (D. Smith and EHB, unpub-
lished). This suggests that both pathways contribute to the
yeast cells arrest in response to mutant telomeric DNA repeats
and that the two pathways can function at least somewhat
redundantly in this role. In interesting contrast to these results,
a mutation in the telomere-protective protein Cdc13p, which
binds the single stranded terminal portion of yeast telomeric
DNA [24], elicited an arrest with genetic requirements that
resembled a DNA damage response; that is, the arrest could
be alleviated by deleting just the DNA checkpoint [23].
In human cancer cells, telomere uncapping is caused by
expression of a telomerase RNA with a mutant template
[25]. In these cells, DNA damage foci can be seen clearly form-
ing at the telomeres themselves, the DNA damage protein p21
is induced, and apoptosis increases. However, again, the genet-
ic dependencies for this cellular response diﬀer from that of a
DNA damage response: p53 is not required. This lack of a
requirement for p53 for the cellular apoptotic response con-
trasts with the dependence on p53 that was reported for a dif-
ferent type of telomere aberrancy in human cells: depletion of
the telomeric binding protein TRF2 from telomeres by overex-
pression of a truncated, dominant negative form of TRF2. In
that case, apoptosis showed a p53 dependence [26].
In summary, the above results suggest that the diﬀerent
kinds of molecular aberrancies at telomeres may initiate signal-
ing within cells diﬀerently from each other, or from double-
stranded DNA breaks. Eventually, the ensuing downstream
events appear to converge on a common DNA damage re-
sponse. How these cellular responses to threats to telomereintegrity are triggered and coordinated remains an important
mechanistic question.
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